Black Diamond Therapeutics, Inc. (BDTX)
1.38
-0.01
(-0.72%)
USD |
NASDAQ |
Nov 20, 09:49
Black Diamond Therapeutics Free Cash Flow : -33.32M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -33.32M |
| June 30, 2026 | -32.84M |
| March 31, 2026 | -34.03M |
| December 31, 2025 | 29.61M |
| September 30, 2025 | 21.35M |
| June 30, 2025 | 17.87M |
| March 31, 2025 | 12.31M |
| December 31, 2024 | -62.30M |
| September 30, 2024 | -61.20M |
| June 30, 2024 | -68.28M |
| March 31, 2024 | -67.92M |
| December 31, 2023 | -66.75M |
| September 30, 2023 | -74.73M |
| June 30, 2023 | -72.81M |
| March 31, 2023 | -76.70M |
| Date | Value |
|---|---|
| December 31, 2022 | -85.27M |
| September 30, 2022 | -87.71M |
| June 30, 2022 | -99.22M |
| March 31, 2022 | -106.97M |
| December 31, 2021 | -102.86M |
| September 30, 2021 | -94.36M |
| June 30, 2021 | -77.88M |
| March 31, 2021 | -65.46M |
| December 31, 2020 | -52.29M |
| September 30, 2020 | -43.89M |
| June 30, 2020 | -37.70M |
| March 31, 2020 | -29.10M |
| December 31, 2019 | -24.67M |
| September 30, 2019 | -19.57M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lineage Cell Therapeutics, Inc. | -26.46M |
| Armata Pharmaceuticals, Inc. | -26.86M |
| Voyager Therapeutics, Inc. | -109.83M |
| Invivyd, Inc. | -134.11M |
| Elicio Therapeutics, Inc. | -36.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.338M |
| Cash from Investing (Quarterly) | 4.218M |
| Cash from Financing (Quarterly) | 0.012M |
| Free Cash Flow Per Share (Quarterly) | -0.1451 |
| Free Cash Flow to Equity (Quarterly) | -7.404M |
| Free Cash Flow to Firm (Quarterly) | -8.338M |
| Free Cash Flow Yield | -42.02% |